Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-23

FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves Exelan Pharmaceuticals' lisinopril and hydrochlorothiazide tablets as an original generic product for treating hypertension. This approval make…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril and Hydrochlorothiazide tablets (lisinopril and hydrochlorothiazide)

Snippet

ORIG AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS)